US2011223687A1PendingUtilityA1

Method for diagnosing non-small cell lung cancer

Assignee: ONCOTHERAPY SCIENCE INCPriority: Mar 23, 2004Filed: May 23, 2011Published: Sep 15, 2011
Est. expiryMar 23, 2024(expired)· nominal 20-yr term from priority
A61P 35/00C12Q 2600/158A61K 31/731C12Q 2600/136C12Q 1/6886C12Q 2600/118A61P 11/00
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are methods for detecting non-small cell lung cancer (NSCLC) using differentially expressed genes KIF11, GHSR1b, NTSR1, and FOXM1. Also disclosed are methods of identifying compounds for treating and preventing NSCLC, based on the interaction between KOC1 and KIF11, or NMU and GHSR1b or NTSR1.

Claims

exact text as granted — not AI-modified
1 . A method of screening for a compound for treating or preventing NSCLC, said method comprising the steps of:
 contacting a KIF11 polypeptide or functional equivalent thereof with KOC1 polypeptide or functional equivalent thereof in the presence of a test compound;   detecting the binding between the polypeptides; and   selecting the test compound that inhibits the binding between the polypeptides.   
     
     
         2 . The method of  claim 1 , wherein the functional equivalent of KIF11 polypeptide comprises amino acid sequence of KOC1 binding domain. 
     
     
         3 . The method of  claim 1 , wherein the functional equivalent of KOC1 polypeptide comprises amino acid sequence of KIF11 binding domain.

Join the waitlist — get patent alerts

Track US2011223687A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.